Goldman Sachs Group Inc Adagio Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 165,377 shares of ADGI stock, worth $547,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
165,377
Previous 151,306 9.3%
Holding current value
$547,397
Previous $500,000 9.4%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
14,071 Added 9.3%
165,377 $547,000
Q2 2024

Aug 13, 2024
SELL
N/A
-451,601 Reduced 74.9%
151,306 $500,000
Q1 2024

May 15, 2024
BUY
N/A
548,770 Added 1013.67%
602,907 $2 Million
Q4 2023

Feb 13, 2024
BUY
N/A
31,186 Added 135.88%
54,137 $179,000
Q3 2023

May 14, 2024
SELL
N/A
-31,186 Reduced 57.61%
22,951 $75,000
Q3 2023

Nov 14, 2023
SELL
N/A
-20,811 Reduced 47.55%
22,951 $75,000
Q2 2023

May 14, 2024
SELL
N/A
-38,555 Reduced 46.84%
43,762 $144,000
Q2 2023

Aug 14, 2023
SELL
N/A
-38,555 Reduced 46.84%
43,762 $144,000
Q1 2023

May 14, 2024
BUY
N/A
17,635 Added 27.26%
82,317 $272,000
Q1 2023

May 11, 2023
BUY
N/A
17,635 Added 27.26%
82,317 $272,000
Q4 2022

May 14, 2024
SELL
$3.08 - $4.05 $233,408 - $306,917
-75,782 Reduced 53.95%
64,682 $214,000
Q4 2022

Feb 13, 2023
SELL
$3.08 - $4.05 $233,408 - $306,917
-75,782 Reduced 53.95%
64,682 $214,000
Q3 2022

May 14, 2024
SELL
$2.97 - $4.83 $808,137 - $1.31 Million
-272,100 Reduced 65.95%
140,464 $440,000
Q3 2022

Nov 10, 2022
SELL
$2.97 - $4.83 $808,137 - $1.31 Million
-272,100 Reduced 65.95%
140,464 $439,000
Q2 2022

May 14, 2024
BUY
$2.54 - $4.52 $910,404 - $1.62 Million
358,427 Added 662.07%
412,564 $1.35 Million
Q2 2022

Aug 15, 2022
BUY
$2.54 - $4.52 $950,572 - $1.69 Million
374,241 Added 976.54%
412,564 $1.35 Million
Q1 2022

May 16, 2022
BUY
$3.81 - $10.77 $58,445 - $165,211
15,340 Added 66.74%
38,323 $175,000
Q4 2021

Feb 14, 2022
BUY
$6.35 - $47.04 $145,942 - $1.08 Million
22,983 New
22,983 $167,000

Others Institutions Holding ADGI

# of Institutions
78
Shares Held
63.9M
Call Options Held
2.3K
Put Options Held
2.1K
View Full List

About Adagio Therapeutics, Inc.

ADGI Quotes by TradingView
  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email